MACQUARIE GROUP LTD
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1418333
Sydney, NSW 2000, C3
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,182
-$6,171,517 QoQ
Shares Held
32
-99.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#354
of 411 holders
Holding Since
Mar 2020
24 quarters on record
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACQUARIE GROUP LTD holds $47,158,112 across 21 Biotechnology names. MDGL ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,980 | $18,865,804 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,532 | $10,931,901 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,943 | $6,304,471 | |
| 4 | INCY |
Incyte Corp
|
33,301 | $3,775,000 | |
| 5 | RPRX |
Royalty Pharma plc
|
41,037 | $2,300,944 | |
| 6 | EXEL |
Exelixis, Inc.
|
27,485 | $1,495,458 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,331 | $623,829 | |
| 8 | INSM |
INSMED Inc
|
5,193 | $553,677 |
All Filings in MDGL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,182 | 32 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $6,188,699 | 13,493 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,944,757 | 19,643 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,968,450 | 15,000 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $4,628,550 | 15,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,183,300 | 15,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,984,560 | 28,500 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $15,743,877 | 58,957 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,594,330 | 28,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,162,140 | 28,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,583,500 | 28,500 | Shares | Sole | 2023-10-27 | |
| 2023-03-31 | $6,904,410 | 28,500 | Shares | Sole | 2023-06-01 | |
| 2022-12-31 | $8,272,125 | 28,500 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $1,907,391 | 29,349 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,111,180 | 29,494 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $2,893,951 | 29,494 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,499,321 | 29,494 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,353,326 | 29,494 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,800,634 | 28,751 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,363,004 | 28,751 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,203,919 | 28,820 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,421,798 | 28,820 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,263,865 | 28,820 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $1,902,660 | 28,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||